These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
4. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800 [TBL] [Abstract][Full Text] [Related]
5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
12. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Nimmrich V; Ebert U Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730 [TBL] [Abstract][Full Text] [Related]
13. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995 [TBL] [Abstract][Full Text] [Related]
14. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study. Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278 [TBL] [Abstract][Full Text] [Related]
15. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease. Takata K; Kitamura Y J Pharmacol Sci; 2012; 118(3):331-7. PubMed ID: 22382659 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model. Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083 [TBL] [Abstract][Full Text] [Related]
17. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ; Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027 [TBL] [Abstract][Full Text] [Related]
18. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease. Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155 [TBL] [Abstract][Full Text] [Related]
19. Synaptic Plasticity, Dementia and Alzheimer Disease. Skaper SD; Facci L; Zusso M; Giusti P CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900 [TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid, neuronal death and Alzheimer's disease. Carter J; Lippa CF Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]